| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 508954 | Finkurve Fin. Finkurve Financial Services Ltd | 13-May-2026 | Finkurve Financial Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Raising of funds by issuance of 11.33% Non-Convertible Debentures having face value of Rs. 10000 (Indian Rupees Ten Thousand only) each and issue price of Rs. 10000 (Indian Rupees Ten Thousand only) through private placement via Electronic Bidding Platform (EBP). |
| 540267 | Flora Corporatio Flora Corporation Ltd | 13-May-2026 | Flora Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve 1. Audited financial results for the quarter and year ended 31.03.2026 2. Appointment of Secretarial Auditor for financial year 2026-27. 3. Any other business with the permission of the Chair. |
| 544616 | Gallard Steel Gallard Steel Ltd | 13-May-2026 | Gallard Steel Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve 1. Approval of the Standalone and Consolidated Audited Financial Results of the Company for the Half year/Year ended 31st March 2026. 2. to take on record the Audit report by the auditors for the Standalone and Consolidated Audited Financial Results of the Company for the Half-year /Year ended 31st March 2026.3. To consider and approve the Standalone and Consolidated Audited Financial Statements including the Balance Sheet as at 31st March 2026 and the Statement of Profits and Loss and Cash flow for the year ended 31st March 2026. 4. Other Routine Business Items. |
| 544525 | GK Energy GK Energy Ltd | 13-May-2026 | GK Energy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026, along with Auditors Report and other business matters. |
| 500660 | Glaxosmi. Pharma Glaxosmithkline Pharmaceuticals Ltd | 13-May-2026 | Glaxosmithkline Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) for the year ended 31st March 2026 and dividend if any |
| 506858 | Guj. Petrosynth. Gujarat Petrosynthese Ltd | 13-May-2026 | Gujarat Petrosynthese Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve the Audited Standalone Financial Results along with Draft Audit Report thereof for the quarter and financial year ended March 31 2026. |
| 500104 | H P C L Hindustan Petroleum Corporation Ltd | 13-May-2026 | Hindustan Petroleum Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results of the Company for the Financial Year ended March 31, 2026 & Recommendation of Final Equity Dividend, if any, for the Financial Year 2025-2026. |
| 539724 | Hypersoft Tech. Hypersoft Technologies Ltd | 13-May-2026 | Hypersoft Technologies Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Standalone and consolidated financial results of the Company for the quarter and year ended 31st March 2026 |
| 531840 | IEC Education IEC Education Ltd | 13-May-2026 | IEC Education Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve As per attachment |
| 539149 | Integ. Capital Integrated Capital Services Ltd | 13-May-2026 | Inter alia, to consider and approve:- (1) the recommendation of the Nomination and Remuneration Committee for appointment of Chief Financial Officer |



